IVGSX
Price
$19.97
Change
+$0.03 (+0.15%)
Updated
Oct 6 closing price
Net Assets
158.14M
RMFCX
Price
$62.20
Change
+$0.11 (+0.18%)
Updated
Oct 6 closing price
Net Assets
112.47B
Interact to see
Advertisement

IVGSX vs RMFCX

Header iconIVGSX vs RMFCX Comparison
Open Charts IVGSX vs RMFCXBanner chart's image
VY® Invesco Growth and Income S
Price$19.97
Change+$0.03 (+0.15%)
VolumeN/A
Net Assets158.14M
American Funds American Mutual R3
Price$62.20
Change+$0.11 (+0.18%)
VolumeN/A
Net Assets112.47B
IVGSX vs RMFCX Comparison Chart in %
View a ticker or compare two or three
VS
IVGSX vs. RMFCX commentary
Oct 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVGSX is a Hold and RMFCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 112B vs. IVGSX (158M). IVGSX pays higher dividends than RMFCX: IVGSX (2.66) vs RMFCX (1.20). IVGSX was incepted earlier than RMFCX: IVGSX (32 years) vs RMFCX (23 years). RMFCX (0.91) and IVGSX (0.89) have similar cost to investors . RMFCX (31.00) and IVGSX (30.00) have comparable annual turnover. IVGSX has a lower initial minimum investment than RMFCX: IVGSX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 7.44 vs. IVGSX (-8.60). RMFCX return over 5 years is better than : 60.80 vs. IVGSX (21.05).
IVGSXRMFCXIVGSX / RMFCX
Total Expense Ratio0.890.9198%
Annual Report Gross Expense Ratio0.890.9198%
Fund Existence32 years23 years-
Gain YTD-9.21214.964-62%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets158M112B0%
Annual Yield % from dividends2.661.20221%
Returns for 1 year-8.607.44-116%
Returns for 3 years6.9343.8416%
Returns for 5 years21.0560.8035%
Returns for 10 years-6.5194.21-7%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UFPT201.936.71
+3.44%
UFP Technologies
VMI400.365.74
+1.45%
Valmont Industries
FRMEP25.80N/A
N/A
First Merchants Corp
LXEO6.47-0.15
-2.27%
Lexeo Therapeutics
KPTI6.16-0.22
-3.45%
Karyopharm Therapeutics Inc.